Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...

Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community. Among the featured data presented at this week’s International ...

REDWOOD CITY, Calif. – July 30, 2012 – Proteus Digital Health, Inc. announced today that the U.S. Food and Drug Administration (FDA) has cleared its ingestible sensor for marketing as a medical device ...

Oracle, a computer technology corporation, is targeting health care as a key vertical market. Reflecting this ambition, the company has announced it now holds a minority stake in medical device maker ...